Injection/Infusion
CISPA CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/50ML
Summary
CISPA CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/50ML — Injection/Infusion containing cisplatin. Hong Kong Registration No. HK-67569. Certificate Holder: JACOBSON MARKETING LIMITED. Date of Registration: 23 Sep, 2022.
Product NameCISPA CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/50ML
Registration No.HK-67569
Certificate HolderJACOBSON MARKETING LIMITED
Holder Address1507D, 15/F, CHINA TRADE CTR, 122-124 WAI YIP ST, KWUN TONG, KOWLOON
Ingredientscisplatin
Dosage FormInjection/Infusion
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration23 Sep, 2022
ATC codesL01XA01
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL01
本頁為藥物資料查詢工具，並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料，僅供參考；一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告（醫藥）條例》之規管。